Aok Rheinland pfalz saarland Die Gesundheitskasse Tender

Contract notice: Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for drugs with the active ingredient zolmitriptan (N02CC03) as part of a so-called open-house model. The AOK Rheinland-Pfalz / Saarland - Die Gesundheitskasse offers all interested pharmaceutical companies without a selection decision discount agreements with the active ingredient zolmitriptan (N02CC03). Contracts are concluded as part of an "open house model". The contracts offered are not exclusive; Contracts with all market participants (pharmaceutical companies) are requested by the AOK Rheinland-Pfalz / Saarland - Die Gesundheitskasse. In the open house model, uniform conditions apply to all participants. The content of the contract, terms and conditions and access procedures are uniform - individual negotiations are not conducted. The contract periods are a maximum of 24 months, the earliest contract start is 1.6.2021. All contracts end no later than 24 months after the date of the earliest commencement of the contract, regardless of the date on which the respective contract was concluded. Joining or entering into a contract can take place within the 24-month period on the first of each month. There is a right of termination 6 weeks to the end of the month according to the provisions of the contract. Further information on the termination options can be found in the contract documents. The AOK Rheinland-Pfalz / Saarland - Die Gesundheitskasse reserves the right to replace the non-exclusive open house discount agreements with exclusive discount agreements within the framework of Europe-wide tendering procedures during the contract period. With the entry into force of advertised, exclusive discount contracts, the open house contracts are terminated in accordance with the contractual regulation, i. H. the open house contracts end automatically.